A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin 0.4 mg Tablets, in Healthy Adult Male Subjects, Under Fed Conditions

NCT07091669 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Male

Interventions

DRUG: Tamsulosin (0.4 mg/j)
DRUG: Tamsulosin (0.4 mg/j)

Sponsor

Berlin-Chemie AG Menarini Group